Intra-Cellular Therapies Inc (NASDAQ:ITCI)
| 42.61 Delayed Data As of Jan 21 |  +3.74 / +9.62%Today’s Change | 28.40 Today|||52-Week Range 55.20 | -18.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 91.4K | 330.7K | 245.8K | 0.00 | |
| Depreciation And Amortization | 139.6K | 196.9K | 213.9K | 368.7K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -368.7K | |
| General Expenses | 105.8M | 118.4M | 102.9M | 161.9M | ||
| Research And Development | 87.7M | 93.8M | 79.4M | 132.2M | ||
| Total Operating Expenses | 105.9M | 118.6M | 103.1M | 162.3M | ||
| Non-Operating Expenses | Operating Income | -105.8M | -118.3M | -102.8M | -162.3M | |
| Interest Expense On Debt | 0.00 | 36.8K | 0.00 | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -104.8M | -115.4M | -98.8M | -155.1M | |
| Income Taxes | -1.6K | -1.1M | -1.1M | -1.6K | ||
| Net Income | -104.8M | -116.4M | -97.8M | -155.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 36.1M | 43.2M | 46.2M | 54.7M | |
| Shares To Calculate EPS Diluted | 36.1M | 43.2M | 46.2M | 54.7M | ||
| Earnings Per Share | EPS | -$2.91 | -$2.69 | -$2.12 | -$2.84 | |
| EPS Diluted | -$2.91 | -$2.69 | -$2.12 | -$2.84 | ||
